Memorial Sloan Kettering Cancer Center MSK Pulmo-Oncology Symposium 2025

• Target Audience: pulmonologists, hematologists, oncologists
• Sample video: contact me for sample video
• Information:

Specialties – Allergy and Immunology, Bone Marrow Transplant, Cardiology, Emergency Medicine, General and Family Practice, Geriatric Medicine, Hematology, Hospice and Palliative Medicine, Hospitalist, Immunotherapy, Infectious Diseases, Integrative Medicine, Internal Medicine, Leukemia, Lymphoma, Medical Oncology, Nurse Practitioner, Nursing, Oncology and Hematology, Pharmacology and Medication Management, Physician Assistant, Pulmonary Medicine, Pulmonology, Radiation Oncology, Respiratory Therapy, Sleep Medicine, Solid Tumor Oncology, Surgical Oncology, Thoracic Medical Oncology, Thoracic Surgery

Overview

Pulmo-oncology is an emerging discipline at the intersection of pulmonary medicine and oncology, playing a critical role in the clinical care of patients with cancer. The respiratory system is often impacted by direct cancer involvement and toxicities stemming from the use of anti-neoplastic agents. Pre-existing pulmonary disorders affect patient outcomes and management decisions. Effective clinical management of pulmonary complications of cancer and its therapies requires an interdisciplinary approach.

Now in its third year, this symposium brings together global experts from multiple disciplines to present the latest advances in cancer therapies and best practices in the evaluation and management of lung disease. Through state-of-the-art presentations and interdisciplinary, case-based discussions, this symposium will explore key topics related to the care of cancer patients with pulmonary comorbidities and complications arising from cancer or its treatments.

Key topics for this year’s program include:

State-of-the-art updates in lung cancer treatment

Navigating immune-mediated lung toxicities related to cancer therapy

Clinical strategies for prevention, symptom management, and co-existing conditions

Complex cases will be presented throughout, with dedicated time for interactive, multidisciplinary panel discussions to encourage meaningful engagement between participants and the faculty.

Format & Audience: This symposium offers the option to attend either in person or virtually and is intended for healthcare professionals in pulmonology, hematology/oncology, and related disciplines involved in the care of cancer patients or those with a special interest in this area.

Objectives

At the conclusion of this symposium, attendees will be able to:

Describe the role of the pulmonologist in diagnosis and management of cancer related pulmonary complications

Identify state of the art diagnostic and treatment strategies for management of lung cancer

Implement strategies for diagnosis and management of non-infectious pulmonary complications of stem cell transplant and other cancer directed therapies

Discuss multidisciplinary approach in complex patients

Implement approaches to symptom management and prevention of cancer related pulmonary complications

Gain insight in sleep disordered breathing in the cancer patient

The MSK Pulmo-Oncology Symposium 2025 by Memorial Sloan Kettering Cancer Center is best for pulmonologists, hematologists/oncologists, and other specialists involved in the care of cancer patients with respiratory complications. It’s ideal for:

Understanding how cancer and anti-neoplastic therapies affect the respiratory system

Managing patients with pre-existing pulmonary disorders and cancer-related lung toxicities

Exploring emerging strategies in pulmo-oncology, a growing interdisciplinary field

• Topics:

Friday, September 19, 2025